文章摘要
吴彤彤,赵俊青,张慧英,刘红,俞丽凝.高频联合低频重复经颅磁刺激对脑卒中后上肢运动功能障碍的疗效观察[J].中国康复,2026,41(10):591-596
高频联合低频重复经颅磁刺激对脑卒中后上肢运动功能障碍的疗效观察
Efficacy of high-frequency combined with low-frequency repetitive transcranial magnetic stimulation for upper limb motor function recovery after acute stroke
  
DOI:10.3870/zgkf.2026.10.003
中文关键词: 脑卒中  上肢运动功能障碍  重复经颅磁刺激  双侧刺激
英文关键词: stroke  upper extremity motor dysfunction  repetitive transcranial magnetic stimulation  bilateral stimulation
基金项目:长治市基础研究计划(自由探索类)项目(JC202421)
作者单位
吴彤彤 1.长治医学院附属和平医院康复科,山西 长治046000;2.长治医学院第一临床学院 
赵俊青 1.长治医学院附属和平医院康复科,山西 长治046000 
张慧英 3.长治医学院附属和平医院神经内科 
刘红 3.长治医学院附属和平医院神经内科 
俞丽凝 3.长治医学院附属和平医院神经内科 
摘要点击次数: 506
全文下载次数: 187
中文摘要:
  目的:探讨高频联合低频重复经颅磁刺激(rTMS)对脑卒中后上肢运动功能障碍的疗效。方法:选取脑卒中后上肢功能障碍患者124例,采用随机数字表法,分为假刺激组(双侧M1区假刺激)、低频组(健侧M1区1Hz rTMS+患侧M1区假刺激)、高频组(患侧M1区10Hz rTMS+健侧M1区假刺激)、联合组[患侧M1区间歇性θ脉冲刺激(iTBS)+健侧M1区1Hz rTMS]4组,每组均31例。iTBS是高频rTMS的一种新形式,具有与传统高频rTMS相当的神经调控效应。4组均接受常规药物及常规康复治疗,在此基础上予以对应的rTMS治疗方案,均治疗4周。最终,4组各有1例脱落,4组均为30例。分别于治疗前、治疗2周后、治疗4周后,采用Fugl-Meyer评定量表上肢部分(FMA-UE)、Wolf运动功能测试(WMFT)、改良Barthel指数评定量表(MBI)、患侧静息运动阈值(RMT)、患侧运动诱发电位(MEP)皮质潜伏期进行评估。结果:治疗2周后及4周后,低频组、高频组、联合组患者患侧MEP皮质潜伏期、患侧RMT随时间推移减少(P<0.05);治疗2周、4周后,低频组、高频组、联合组患者患侧MEP皮质潜伏期、患侧RMT均低于对照组(P<0.05),联合组更低于低频组和高频组(P<0.05),高频组和低频组比较差异无统计学意义。治疗2周后及4周后,低频组、高频组、联合组患者FMA-UE、WMFT、MBI评分随时间推移增加(P<0.05);3组FMA-UE、WMFT、MBI评分均高于对照组(P<0.05),联合组更高于低频组和高频组(P<0.05),高频组和低频组比较差异无统计学意义。结论:高频联合低频rTMS治疗对急性脑卒中后上肢运动功能的恢复有效,且优于单一rTMS治疗。
英文摘要:
    Objective: To investigate the efficacy of high-frequency combined with low-frequency repetitive transcranial magnetic stimulation (rTMS) in promoting upper limb motor function recovery after acute stroke. Methods: A randomized controlled design was adopted, and 124 patients with acute stroke were divided into 4 groups (n=31 per group). All 4 groups received routine medication and conventional rehabilitation treatment, on the basis of which different rTMS protocols were administered: the sham stimulation group (sham stimulation over bilateral primary motor cortices M1), the low-frequency group (1 Hz rTMS over the unaffected M1 + sham stimulation over the affected M1), the high-frequency group (10 Hz rTMS over the affected M1 + sham stimulation over the unaffected M1), and the high-frequency combined with low-frequency group [intermittent theta-burst stimulation (iTBS) over the affected M1+1 Hz rTMS over the unaffected M1], once daily, 5 days per week for a total of 4 weeks. iTBS is a novel paradigm of high-frequency rTMS, and its neuromodulatory effects are consistent with those of conventional high-frequency rTMS. Before treatment, after 10 sessions and 20 sessions of treatment, the Fugl-Meyer assessment of upper extremity (FMA-UE), Wolf motor function test (WMFT), modified Barthel index (MBI), resting motor threshold (RMT) of the affected side, and cortical latency of motor evoked potential (MEP) of the affected side were used for evaluation. Results: After 2 and 4 weeks of treatment, the affected-side MEP cortical latency and affected-side RMT in the low-frequency group, high-frequency group and combined group decreased over time (all P<0.05). At both follow-up time points, the above two indicators in the thr-ee intervention groups were all lower than those in the control group (all P<0.05), and the combined group had even lower values than the low-frequency group and high-frequency group (all P<0.05), while no statistically significant difference was found between the high-frequency group and the low-frequency group. After 2 and 4 weeks of treatment, the FMA-UE, WMFT and MBI scores in the low-frequency group, high-frequency group and combined group increased over time (all P<0.05). At the two time points, the above scores in the three intervention groups were all higher than those in the control group (all P<0.05), and the combined group yielded even higher scores than the low-frequency group and high-frequency group (all P<0.05), while the difference between the high-frequency group and the low-frequency group was not statistically significant. Conclusion: Combined high-frequency and low-frequency rTMS is effective in promoting upper limb motor function recovery after acute stroke, and its efficacy is superior to that of monomodal rTMS monotherapy.
查看全文   下载PDF阅读器  HTML全文
关闭
本刊微信二维码